// App-Quantinova.ai

TCT-149 : Impact of Chronic Kidney Disease on Myocardial Infarct Size and Adverse Events in ST-Elevation Myocardial Infarction: Results from the INFUSE-AMI Trial

Researchers

Presenter

  • Usman Baber

Principal Investigators

  • Roxana Mehran

  • Sorin Brener

  • Akiko Maehara

  • Dariusz Dudek

  • Thomas Neunteufl

  • D. Christopher Metzger

  • C. Michael Gibson

  • Gregg Stone

Medical Centers

  • The University Hospital, Krakow, Poland

  • Department of Pediatrics, New York Methodist Hospital, Brooklyn, NY

  • Cardiovascular Research Foundation and Columbia University Medical Center, New York, United States

  • Mount Sinai School of Medicine, New York, NY

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

Locations

  • Poland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Chronic kidney disease

  • Renal disease

  • Venous thrombosis

Biomarkers

  • Creatinine

Drug/Treatment

  • Abciximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved